Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-26

Clinical Trial Update: Direct Lentiviral Injection Gene Therapy for MLD [NA]

View source ↗

Summary

This entry notes that Shenzhen Geno-Immune Medical Institute is recruiting for a direct lentiviral injection gene therapy trial for Metachromatic Leukodystrophy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Direct lentiviral injection gene therapy for Metachromatic Leukodystrophy

Snippet

Sponsor: Shenzhen Geno-Immune Medical Institute | Conditions: Metachromatic Leukodystrophy (MLD) | NA | Status: RECRUITING